id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-350718-jzliir37	Madrazo-González, Z.	Anemia and transfusion therapy: an update	2011-12-31		.txt	text/plain	6500	429	45	34, 38 The therapeutic possibilities in relation to anemia in the critical patient (analyzed more in detail below) can be grouped as follows: ABT; drug treatment (erythropoietic stimulators, iron therapy, antifibrinolytic / hemostatic agents); autologous blood donation and/or reinfusion programs; and restrictive and individualized transfusion criteria. 16 The EORTC (European Organization for Research and Treatment of Cancer) and SEOM (Spanish Society of Clinical Oncology) guides on the use of ESAs in anemia in neoplastic patients confirm their efficacy in increasing the hemoglobin levels, reducing the need for transfusions (by up to 50%) and improving patient quality of life, though without consistent data confirming improvement in patient survival, local tumor control, time to disease progression or disease-free interval. evidenced a tendency towards lessened transfusion needs, inflammatory response and mortality in critical patients with anemia administered intravenous iron saccharose (alone or combined with ESAs).	./cache/cord-350718-jzliir37.txt	./txt/cord-350718-jzliir37.txt